Disposition of perfluorobutane in rats after intravenous injection of Sonazoid™

This publication has 17 references indexed in Scilit:

• Gene Transfer with Echo-enhanced Contrast Agents: Comparison between Albunex, Optison, and Levovist in Mice—Initial Results
  Radiology, 2003
• Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres
  Cell and tissue research, 2003
• Hepatic Tumor Detection: MR Imaging and Conventional US versus Pulse-Inversion Harmonic US of NC100100 during Its Reticuloendothelial System–Specific Phase
  Radiology, 2002
• Predictive value of markers of myocardial reperfusion in acute myocardial infarction for follow-up left ventricular function
  The American Journal of Cardiology, 2001
• Delivery of Drugs with Ultrasound
  Echocardiography, 2001
• Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography
  Ultrasound in Medicine & Biology, 2001
• Determination of perfluorobutane in rat blood by automatic headspace capillary gas chromatography and selected ion monitoring mass spectrometry
  Journal of Pharmaceutical and Biomedical Analysis, 2001
• Physiologically based pharmacokinetic model for fluorocarbon elimination after the administration of an octafluoropropane-albumin microsphere sonographic contrast agent.
  Journal of Ultrasound in Medicine, 1999
• Tissue Distribution of¹²⁵ l-LabeIed Albumin in Rats, and Whole Blood and Exhaled Elimination Kinetics of Octafluoropropane in Anesthetized Canines, Following Intravenous Administration of Optison® (FS069)
  International Journal of Toxicology, 1999
• Intraoperative Perfluorocarbon Liquids in the Management of Proliferative Vitreoretinopathy
  American Journal of Ophthalmology, 1988